Cannabis Science (CBIS) Now that`s a “Shot of Steroids in the arm News”! CBIS released another solid press release Monday and seems to be on a news rampage closing higher on a solid day of trading. No doubt our Research Report took noticed today and with 500%+ potential returns, there are a lot of eyes on CBIS.

Direct Global Media’s recent revised report on DROP (DEGH) – http://srv.ezinedirector.net/n44496&s7667683 rallied big time when they released their price target, jumping as much as 20,000% and exactly hitting their $1.25 target – when Direct Global Media puts out their report, people listen.

Read CBIS research report that was released this weekend Visit xtremepicks.com to get the CBIS research report FREE.

For additional information on this report or advertising inquiries, contact http://srv.ezinedirector.net/n44497&s7667683 at contact@directglobalmedia.com Article except: ” It doesn`t take a rocket scientist to realize that this industry is growing and that there are untold riches to be made here,” said Troy Dayton, the chief executive of the ArcView Group.” CLICK HERE FOR THE REPORT Be sure to watch our discussion on our Twitter and Facebook sites and definitely join the discussions with our new SKYPE Chat Room JOIN us in our SKYPE Chat Room Today! It’s free, and it’s easy to join. If you do not have Skype, it can be downloaded at http://srv.ezinedirector.net/n44498&s7667683 Skype name: xtremepicks http://srv.ezinedirector.net/n44499&s7667683 CBIS closed Monday at $0.15 up 18.11% with heavy trading showing solid liquidity in the market. Members following our $0.04 price alert are up close to 300%+ gains. News today by the company just goes to show you that they are looking at “blue skies” ahead and a step closer to a bullish breakout.

CBIS Chart Cannabis Science Targets Opportune Immediate European Expansion With Acquisitions & Licensing Deals; Negotiations For First European Deal Is In Final Stages For New Products, Revenues, and Management Cannabis Science, Inc. (OTCBB:CBIS.ob), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce final negotiations to target an immediate European expansion with opportune acquisitions & licensing deals. This new set of deals is designed to bring to bring new products, revenues, and executive management to the company’s growing operations. The target European company has already created its footprint distributing its products in the European Markets and around the world while meeting Cannabis Science’s standards to ensure the utmost quality control and stringent procedures. more About Cannabis Science, Inc.

Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.

The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

Keep your eyes peeled for the latest updates on our twitter page, facebook page, and our website at http://srv.ezinedirector.net/n44500&s7667683 Xtremepicks.com your trading connection and remember to always do your own research, use stop loss orders to protect yourself, and book your profits when in a position to do so.

Xtremepicks.com profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale. Xtremepicks did not received any compensation for CBIS and may be buyers in the open market. Verify all claims and do your own due diligence.. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. view the full disclaimer Xtremepicks.com 2009 Home | Disclaimer

CBIS · DEGH · DROP · SKYPE

CBIS – The opportunity is there for the taking! CBIS had another record breaking session with another all-time HIGH of $0.2455 and 500%+ for members who jumped on our alert at $0.04 – a record breaking day with volumes of 116 Million shares traded! CBIS definitely had some wild trading action today and gave investors several opportunities to jump in for a solid position at cheap levels. Look for these opportunities and jump on them, this is where the GAINS are made! DROP Chart Our 83,000% monster winner DROP (DEGH), had several minor pullbacks (Blue circles) just before its initial trigger breakout point to our $0.75 target and the continuation breakout towards $1.25 and 83,000% gains! Investors who sold way too early and at prices way too low, missed out on as much as 20,000% breakout trigger gains. Not to mention investors who did not act at all missing out on a potential 83,000% gainer.

CBIS is not even close to its maximum potential gain – smart buyers see this and are accumulating a solid position at these low levels. As more solid updates is unleashed by the company the prices will follow – this is where the real $$s will be made.

http://srv.ezinedirector.net/n29721&s7675653 http://srv.ezinedirector.net/n29722&s7675653 Direct Global Media will also be issuing a Special Research Report on Cannabis Science (CBIS) – Revolutionizing the Medical Industry. Stay tuned for the release this weekend.

CBIS closed at $0.163 on another record breaking volume of 116 Million shares. With news in high anticipation, CBIS can break these records in a heartbeat.

CBIS Chart CBIS series of press releases over the past month is definitely building towards a monster release – a worthy read and recap:

Headlines Cancer Drug Market Evolves – Cannabis Science and ARIAD Pharmaceuticals Poised to BenefitMarketwire(Mon Feb 27) Cannabis Science Chief Operating Officer Dr. Moe Afaneh, Pharm D., MBA, NRCC, Confirms Newest Cannabis Science Brand Product Line & Begins Manufacturing and National Distribution Negotiations to Immediately Release The New Product LineBusiness Wire(Fri Feb 24) Cannabis Science Presents Newest Case Photos of the 3rd Critical Squamous Cell Carcinoma Self-Medicated Cannabis Patient with Clear Continued ImprovementBusiness Wire(Thu Feb 23) A&E Begins Filming An 8-episode Documentary With Cannabis Science’s Newly Appointed Director of Horticulture Bret Bogue; Focused On Bret Bogue, World Renowned Medical Cannabis CultivatorBusiness Wire(Wed Feb 22) Cannabis Science Appoints Former Walgreens Executive Pharmacist Dr.. Moe Afaneh, Pharm D., MBA, NRCC, RNC as Chief Operating Officer (COO) To Immediately Bring the Cannabis Science Brand of Products to the National MarketBusiness Wire(Thu Feb 16) Cannabis Science Signs Multi-Company Acquisition & Licensing Deals that will Boost Revenues, Its Pharmaceutical Operations and Management Team While Bringing Cannabis Science Brand Products For National DistributionBusiness Wire(Tue Feb 14) Cannabis Science Awaits Full Biopsy Report As Newest Series of Photos Shows Cancer Lesion Evidently Completely Killed & Hair Re-growth Begins On New Healthy Skin From 2nd Self-Administering Cancer PatientBusiness Wire(Tue Feb 7) Cannabis Science Issues Corporate & Operations Guidance to Shareholders in Regards to Dividend, Market Potential, and Anecdotal ReportsBusiness Wire(Thu Feb 2) Cannabis Science Reports Success For 4th Brand New Self-Administering Cancer PatientBusiness Wire(Thu Feb 2) FDA Fast-Tracks New Cancer Drug for Skin Cancer While Cannabis Science Offers Topical Treatment for Basal Cell Carcinoma with No Apparent Side EffectsBusiness Wire(Wed Feb 1) About Cannabis Science, Inc.

Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.

The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

Follow us on twitter at http://srv.ezinedirector.net/n29723&s7675653 and become the first to see what our next HOT Stock Pick will be.

Compensation: Ourhotstockpicks has not been compensated for the profile of CBIS .

Ourhotstockpicks.com profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. Ourhotstockpicks may be buyers of features in the open market. view the full disclaimer

ARIAD · CBIS · DEGH · DROP · NRCC

DROP – Watch for a Special Hot Stock Update on Tuesday Feb 21, 2012.

We have a special update on one of our long term plays on Tuesday Feb. 21, 2012, similar to our Monster play DROP which gave us 83,000% in gains.

Keep a close eye on our Twitter and Facebook pages for our Special Update.

Understanding Reverse Merger play is the first step in making significant profits – following this theory would have made investors millionaires in DROP (DEGH):

Phase 1: Pioneer Investors Out of the ordinary occurrence in a stock with little or no recent activity. http://srv.ezinedirector.net/n95518&s7675653 DROP delayed their filings just before the reverse merger announcement. The volume primarily originates from those with ‘inside’ knowledge that a merger may be on the horizon. DROP traded close to $0.01.

Phase 2: Off to the races Management informs shareholders that they are working towards a reverse merger candidate. Typically, the candidate is already identified and the company is either finalizing the details or just stalling to entice market activity and investors. Speculation build and stock prices increases and may go through several peaks and consolidation levels as more information is released. This can be overlapping into phase 3 and would typically have announced the reverse merger candidate towards the end of the phase but structure is not complete.

Stage 3: High Speculation This is the most unpredictable phase and can overlap from phase 2 as the company announces the structure of the reverse merger. As more and more investors realize the potential of the merged entity, speculation goes wild as with the case of DROP topping $1.25 Stage 4 & 5: Quality Check Valuation and price movement is dependent upon the new management team and business plan it has developed. This also is a transition from short term speculative investors to long term, valued investors including institutional players. This is a key phase as it transitions to a solid business plan (phase 5) in action. Price adjustment may occur as the investor base significantly changes. This can also be a huge advantage as prices may drop to significantly undervalued levels. Thus is the case with DROP and we are identifying this level as a mega opportunity to scoop some undervalued stock for the transition phase into a full producing company.

Don`t miss this next entry level for monster breakout now.

DROP closed at $0.36 up 9% yesterday and moving higher in early trading today. We see DROP as a prime time to load up for the next breakout.

DROP Chart DROP‘s product demand have been booming and no wonder with endorsements like Tiger Woods, David “Big Papi” Ortiz, and Arian Foster – we are anticipating another monster update to be unleashed by the company that will top these superstars.

DROP‘s recent launch on Amazon.com caught the attentions of many athletes around the world selling out their product in record time.

As the result, DROP‘s solid management and quick response to the exponential growth recently announce a partnership with Smart Warehousing that will definitely give a boost to DROP’s sales and inventory management.

Fuse Science Opens New Headquarters and Partners with North American Supply Chain Expert Smart Warehousing to Support Growth “Our business is advancing rapidly and we’re taking every action necessary to stay in front of our growth curve,” said Brian Tuffin, Chief Executive Officer “These moves advance our company beyond the temporary overflow challenges due to EnerJel™ demand at launch and set the stage for marked progress against our corporate objectives in 2012,” added Tuffin. “We remain extremely confident about the future ahead of this company as we advance our licensing efforts, continued growth of EnerJel™ and the launch of our HydroFuse™ and PowerFuse™ drop technology later this year.” Since then, the company added a HUGE infusion of CASH to the company that will give it a big boost to their overall operations, and adding more strength to their top notch management team:

Previous Merck and Bayer Executive Accepts Full Time Role and Company Adds More Experience to Fuse Science Management Team DROP is definitely building a solid company and a long term investment that can make monster gains! About FUSE Science Fuse Science Inc. is a company made from leading scientific minds and consumer product industry experts with a common goal to raise the standard of product performance through science in key multi-billion dollar categories. We leverage our global leading science to completely change the rules of the game. We’ve discovered through a combination of pending patents and trade secrets that we can now encapsulate nutrients, actives and other molecules at a far greater concentration than any time in history… What use to require consuming an 8 oz energy drink can be done with safer formulations and faster results in a single drop.

Fuse Science breakthroughs can deliver Energy, Nutrition, Medication, Skin Care and an endless number of other products with faster absorption, quicker results and better efficacy.

Follow us on twitter at http://srv.ezinedirector.net/n95519&s7675653 and become the first to see what our next HOT Stock Pick will be.

Compensation: Ourhotstockpicks has not been compensated for the profile of DROP.

Ourhotstockpicks.com profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. Ourhotstockpicks may be buyers of features in the open market. view the full disclaimer

DEGH · DROP

SPLI, SATM, and a Lovely Gem SPLI We have been terribly serious about our involvement in establishing investor awareness to SPLI, as of late. We told you to expect a massive run and for good reason. Today SPLI shot up 64.71% and the awareness kick-off has only just begun.

Look out for a great deal to transpire with SPLI and massive moves before closing out the year. As we said, “prepare to be surprised by SPLI.” Will you be left behind SATM We continue to keep SATM in major play for good reason. Today SATM moved up another 80.72% This movement sets the stage for what is soon to come. REMEMBER: We expect SATM to take off hard at the very start of January and continue reaping massive profits for investors throughout 2012. You will want to start keeping a VERY close eye on SATM. It has been a long hall but we truly believe that all invested here will be seeing significant movement as the story progresses.

****Now for that “Lovely Gem.”****

Our long time subscribers recognize how long we have covered “DEGH,” or better yet, after merger completions, it is now known as “DROP.” We initially covered it heavily until it saw more than 3,000% increases. After this plateau we have covered it over the weeks via our twitter and facebook accounts, and are proud to say that as of today DROP IS NOW UP 6,025%!!! Trading at $0.98 after our initial call at $.016 Remember that we do not quickly jump from play to play but rather stick steadfast to stocks that we truly believe to be winners. In the end, it’s that mentality that sees the greatest profit in the long run. Congratulations to all of the Millionaires that we have created with that play and congratulations for the future millionaires that we are destined to create.

~Happy Trading THE BIRD GANG Disclaimer The disclaimer is to be read and fully understood before using our site, joining our email list, or viewing any releases that birdgangstocks.com releases via any medium. This especially includes online social networking sources, text messages, advertisements, and the spoken word.

PLEASE NOTE WELL: The Birdgangstocks.com employees are not Registered as Investment Adviser’s in any jurisdiction whatsoever.

Release of Liability: Through use of this website viewing or using, you agree to hold Birdgangstocks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. We are engaged in the business of marketing and advertising companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Birdgangstocks.com`s sponsored advertisements do not purport to provide an analysis of any company`s financial position, operations or prospects and this is not to be construed as a recommendation by Birdgangstocks.com or an offer or solicitation to buy or sell any security.

Neither the owners of Birdgangstocks.com nor any of its members, officers, directors, contractors or employees are licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of incredibly high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is highly possible that a viewer`s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. To review our complete disclaimer and additional information, please visit Birdgangstocks.com. Birdgangstocks.com makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors.

Birdgangstocks.com electronically disseminates the Information on its Websites, in newsletters, featured reports and spam compliant double-opt in email communications pertaining to Profiled Companies’ (the “Issuer” or “Issuers” or “Profiled Company” or “Profiled Companies”), the securities of which are most frequently common stock shares quoted on the Over the Counter Bulletin Board (“OTCBB”) or Pink Sheets (the “Securities”). In signing up to any of our (“Our,” the Bird Gang Stocks LLC meaning websites, you agree to allow your e-mail address to be utilized by any of our websites. We will never sell your e-mail address information to any other third parties.

THERE IS NO GUARANTEE THAT YOU WILL EARN ANY MONEY USING THE TECHNIQUES AND IDEAS IN THESE MATERIALS. EXAMPLES IN THESE MATERIALS ARE NOT TO BE INTERPRETED AS A PROMISE OR GUARANTEE OF EARNINGS. EARNING POTENTIAL IS ENTIRELY DEPENDENT ON THE PERSON USING OUR PRODUCT/SERVICE, AS WELL AS THEIR IDEAS AND TECHNIQUES. WE DO NOT PURPORT THIS AS A “GET RICH SCHEME.” ANY CLAIMS MADE OF ACTUAL EARNINGS OR EXAMPLES OF ACTUAL RESULTS ARE NOT TYPICAL. YOUR LEVEL OF SUCCESS IN ATTAINING THE RESULTS CLAIMED IN OUR MATERIALS DEPENDS ON THE TIME YOU DEVOTE TO THE PROGRAM, IDEAS AND TECHNIQUES MENTIONED, YOUR FINANCES, KNOWLEDGE, AND VARIOUS SKILLS. SINCE THESE FACTORS DIFFER ACCORDING TO INDIVIDUALS, WE CANNOT GUARANTEE YOUR SUCCESS OR INCOME LEVEL, NOR ARE WE RESPONSIBLE FOR ANY OF YOUR ACTIONS. MATERIALS IN OUR PRODUCT/SERVICE AND OUR WEBSITE MAY CONTAIN INFORMATION THAT INCLUDES OR IS BASED UPON FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF THE SECURITIES LITIGATION REFORM ACT OF 1995. FORWARD-LOOKING STATEMENTS GIVE OUR EXPECTATIONS OR FORECASTS OF FUTURE EVENTS. YOU CAN IDENTIFY THESE STATEMENTS BY THE FACT THAT THEY DO NOT RELATE STRICTLY TO HISTORICAL OR CURRENT FACTS. THEY USE WORDS SUCH AS “ANTICIPATE,” “ESTIMATE,” “EXPECT,” “PROJECT,” “INTEND,” “PLAN,” “BELIEVE,” AND OTHER WORDS AND TERMS OF SIMILAR MEANING IN CONNECTION WITH A DESCRIPTION OF POTENTIAL EARNINGS OR FINANCIAL PERFORMANCE. ANY AND ALL FORWARD LOOKING STATEMENTS HERE OR ON ANY OF OUR SALES MATERIAL ARE INTENDED TO EXPRESS OUR OPINION OF EARNINGS POTENTIAL. MANY FACTORS WILL BE IMPORTANT IN DETERMINING YOUR ACTUAL RESULTS AND NO GUARANTEES ARE MADE THAT YOU WILL ACHIEVE RESULTS SIMILAR TO OURS OR ANYBODY ELSES, IN FACT NO GUARANTEES ARE MADE THAT YOU WILL ACHIEVE ANY RESULTS FROM OUR IDEAS AND TECHNIQUES IN OUR MATERIAL.

The Information is presented only as a brief “snapshot” of the Profiled Company and should only be used, at most, and if at all, as a starting point for Readers to conduct a thorough investigation of the Profiled Company and its securities, to consult with their financial, legal or other advisor(s) and avail themselves of filings and information at www.birdgangstocks.com/privacy View this email on the web here:

http://mim.io/24b312fe=1&pact24416535

BASED · DEGH · DROP · ELSES · FACTS · GIVE · OURS · SATM · SPLI

Xtremepicks.com Facebook | Xtremepicks.com Twitter | Xtremepicks.com RRS Feed | Xtremepicks.com HALL OF FAME! DROP – 50,000% LBSR – 4,500% HLNT – 1,400% VCTY – 1,500% DROP (DEGH) – How this reverse merger gave members 50,000%+ gains! Our feature picks are no one day wonders but long term plays for long term gains – this is where the true gains are made and nothing better proves it than Fuse Science (DROP) with Friday`s closing at near all-time highs.

Reverse merger plays like DROP can make investors significant returns in all phases. The key to solid reverse merger plays is patience and accumulating on key consolidations. Even if you missed out on our 50,000% gain with our original alert at $0.0015, members had another solid opportunity to jump in on our re-alert at $0.13.

We are always on the lookout for reverse merger potentials like DROP. Understanding Reverse Merger is the first step in making significant profits – following this theory have made investors millionaires in DROP:

Phase 1: Pioneer Investors [DROP50000] -Getting in early can maximize your gains.

Out of the ordinary occurrence in a stock with little or no recent activity. In the case with DROP, the company delayed their filings just before the reverse merger announcement. The volume primarily originates from those with ‘inside’ knowledge that a merger may be on the horizon. DROP traded between $0.0015 and $0.01 Phase 2: Off to the races Management informs shareholders that they are working towards a reverse merger candidate. Typically, the candidate is already identified and the company is either finalizing the details or just stalling to entice market activity and investors. Speculation build and stock prices increases and may go through several peaks and consolidation levels as more information is released. This can be overlapping into phase 3 and would typically have announced the reverse merger candidate towards the end of the phase but structure is not complete.

Stage 3: High Speculation This is the most unpredictable phase and can overlap from phase 2 as the company announces the structure of the reverse merger. As more and more investors realize the potential of the merged entity, speculation goes wild as with the case of DROP topping $0.75.

Stage 4 & 5: Quality Check Valuation and price movement is dependent upon the new management team and business plan it has developed. This also is a transition from short term speculative investors to long term, valued investors including institutional players. This is a key phase as it transitions to a solid business plan (phase 5) in action. Price adjustment may occur as the investor base significantly changes. This can also be a huge advantage as prices may drop to significantly undervalued levels. Thus is the case when we issued a re-alert on DROP at $0.13 identifying this level as a mega opportunity to scoop some undervalued stock for the transition phase into a full producing company- we were bang on as DROP closed at $0.74 adding to our monster gains already with much more to come.

With DROP approaching our near term target again of $0.75 and well into Phase 5, we will be revisiting our Research report and revised price targets shortly.

Our recent DROP research report by Directglobalmedia.com can be found at http://srv.ezinedirector.net/n80968&s7667683 No one else can claim these types of Mega Gains we are seeing in DROP, and we were right on the money with our suspicions starting back as early as May 2010 and with headlines like:

(Note: DEGH changed their symbol to DROP) DEGH – Reverse Merger plays very much in Play for HUGE Gains. – October 6th, 2011 – re-alert at $0.13 DEGH – Making new Millionaires every day with these picks. – July 12th, 2011 DEGH – This stock can make your year! – February 14th, 2011 DEGH – Your path to retirement! – February 01st, 2011 DEGH – We knew we were on to something and they confirmed it today! – January 06th, 2011 and of course the one that started it all May 17th, 2010: DEGH … picks are rocking and rolling.

Our recent success has always been based on our successful trading strategy that profits are made from shifting gains from short term traders to long term investors, and nothing can be more than the truth that what we seen today.

About Double Eagle Holdings Double Eagle Holdings (OTCQB: DROP) is the parent company of Fuse Science, Inc., an innovative consumer products holding company based in Aventura, Florida. The corporate name, Double Eagle Holdings is in the process of being changed to Fuse Science Inc. Fuse Science is the developer of new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. The company has successfully developed and maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly – all in a concentrated “DROP” form that is simply applied under the tongue. The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products. Information about Fuse Science is available online at www.fusescience..com or by calling 305-503-FUSE (3873).

Xtremepicks.com your trading connection and remember to always do your own research, use stop loss orders to protect yourself, and book your profits when in a position to do so.

Xtremepicks.com profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale. Verify all claims and do your own due diligence. Xtremepicks did not receive any compensation for DROP and at times may buy features in the open market. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. view the full disclaimer

DEGH · DROP · FAME · HALL · HLNT · LBSR · VCTY